Cita APA

Cortes, J. E., Nicolini, F. E., Wetzler, M., Lipton, J. H., Akard, L., Craig, A., . . . Kantarjian, H. M. (2013). Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib.

Chicago Style Citation

Cortes, Jorge E., et al. Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib. 2013.

Cita MLA

Cortes, Jorge E., et al. Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib. 2013.